1. Introduction {#sec1}
===============

*Coxiella burnetii* is the aetiology of 1--8% of bacterial endocarditis cases. Endocarditis is the most common form of persistent Q fever worldwide, while the manifestations of acute Q fever are asymptomatic infection, flu-like symptoms, pneumonia, or hepatitis, but not endocarditis \[[@B1]\]. Cases of coinfections of persistent Q infection and other bacteria as the causes of endocarditis were described previously \[[@B2], [@B3]\], but not coinfections of acute Q fever and other bacterial endocarditis.

2. Case Presentation {#sec2}
====================

A 58-year-old healthy male was admitted to the internal medicine department due to weakness, fever, and night sweats for two months. On physical examination, a systolic heart murmur 3/6 was heard over the left sternal border. Abnormal laboratory findings included leukocytosis of 14,000 per microliter, hemoglobin of 9.9 gr/dL, and C-reactive protein (CRP) of 79 mg/L. Five sets of blood cultures were positive for *Streptococcus cristatus*, and transesophageal echocardiography (TEE) revealed severe aortic regurgitation with a large vegetation and moderate mitral regurgitation. The patient was treated with intravenous ceftriaxone and gentamicin and was referred to an aortic valve replacement, from which he recovered without complications. An immunofluorescent assay (IFA) for Q fever (methods described by Siegman-Igra et al. \[[@B4]\]) was positive for acute infection (phase II IgM = 100; phase II IgG = 400), and due to his risk factors for a persistent infection, he was treated with doxycycline and hydroxychloroquine, for a year, without adverse events or progression to a persistent infection. Follow-up serologic test results are given in [Table 1](#tab1){ref-type="table"}.

Two similar patients were treated in our hospital. The first was a 72-year-old male with a prosthetic aortic valve, who was admitted due to one month of fever, weight loss, and weakness. He had splenomegaly and a purpuric rash in both legs, mild pancytopenia, and blood cultures that grew *Enterococcus faecalis* (three sets). TEE was unremarkable, and the patient was treated with intravenous ampicillin and gentamicin for six weeks with a good clinical recovery. The other patient was a 62-year-old male, with a prosthetic mitral valve, who was admitted due to four days of transient diplopia and fever. He had unremarkable physical examination, brain tomography, and TEE. He had elevated CRP of 109 mg/L and mild leukocytosis of 12,500 per microliter. *Streptococcus gordonii* grew in 9 sets of blood cultures, and he was treated with intravenous penicillin and gentamicin for 6 weeks.

Both of these patients had a 4-fold increase of phase II IgG that confirmed a diagnosis of acute Q fever, and they were treated with doxycycline and hydroxychloroquine for 4 and 12 months, respectively, and both had no clinical or laboratory signs of a persistent infection.

3. Discussion {#sec3}
=============

Diagnosis of acute Q fever is based on serology, and the infection is asymptomatic in half of the cases \[[@B1]\]. Our patients definitely had acute Q infection, but the exact timing of the infection is less clear. We think that our patients have been exposed to the pathogen, with an asymptomatic or mild disease rather than a true coinfection. Since molecular tests from infected valves were not available, this remains a speculation.

Our patients had risk factors for recurrent endocarditis and were offered a prolonged antimicrobial treatment to reduce the risk for a persistent infection \[[@B5]\]. None of them progressed to such an infection. Should clinicians look for *Coxiella burnetii* in all patients with risk factors for a persistent infection, even when alternative diagnoses exist? This issue was not investigated in valvulopathies, but screening patients who are at high risk for a persistent vascular infection has been described previously and revealed 17% seropositive patients in the Netherlands \[[@B6]\]. Further studies are needed to establish an evidence-based policy.
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Clinical, bacteriological, serological, and echocardiographic characteristics of three patients with bacterial endocarditis.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient   Previous risk factors                                 Results of blood cultures   Pathological echocardiographic findings              Surgery                    First serology for Q fever   Duration of prophylaxis                                                               Follow-up serology for Q fever (6--12 months from diagnosis)   Follow-up serology for Q fever (3--6 months from end of therapy)
  --------- ----------------------------------------------------- --------------------------- ---------------------------------------------------- -------------------------- ---------------------------- ------------------------------------------------------------------------------------- -------------------------------------------------------------- ------------------------------------------------------------------
  1         None                                                  *Streptococcus cristatus*   Severe aortic regurgitation and a large vegetation   Aortic valve replacement   IgM II-100\                  12 months                                                                             IgM II-negative\                                               NA
                                                                                                                                                                              IgG II-400\                                                                                                        IgG II-200\                                                    
                                                                                                                                                                              IgM I-negative\                                                                                                    IgM I-negative\                                                
                                                                                                                                                                              IgG I-200                                                                                                          IgG I-negative                                                 

                                                                                                                                                                                                                                                                                                                                                                

  2         Aortic valve replacement and aortic composite graft   *Enterococcus faecalis*     None                                                 NA                         IgM II-negative\             4 months (stopped due to side effects: hyperpigmentation of the gingiva and calves)   IgM II-negative\                                               IgM II-negative\
                                                                                                                                                                              IgG II-400\                                                                                                        IgG II-100\                                                    IgG II-100\
                                                                                                                                                                              IgM I-negative\                                                                                                    IgM I-negative\                                                IgM I-negative\
                                                                                                                                                                              IgG I-100                                                                                                          IgG I-negative                                                 IgG I-negative

                                                                                                                                                                                                                                                                                                                                                                

  3         Mitral valve replacement                              *Streptococcus gordonii*    None                                                 NA                         IgM II-negative\             12 months                                                                             IgM II-negative\                                               IgM II-negative\
                                                                                                                                                                              IgG II-200\                                                                                                        IgG II-400\                                                    IgG II-1600\
                                                                                                                                                                              IgM I-negative\                                                                                                    IgM I-negative\                                                IgM I-negative\
                                                                                                                                                                              IgG I-negative                                                                                                     IgG I-200                                                      IgG I-400
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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